PD-Rx Pharmaceuticals, Inc. (PDRX)
OTCMKTS · Delayed Price · Currency is USD
3.330
+0.430 (14.83%)
At close: Jan 12, 2026

PD-Rx Pharmaceuticals Statistics

Total Valuation

PDRX has a market cap or net worth of 5.48 million. The enterprise value is -689,176.

Market Cap5.48M
Enterprise Value -689,176

Important Dates

The last earnings date was Thursday, November 20, 2025.

Earnings Date Nov 20, 2025
Ex-Dividend Date n/a

Share Statistics

PDRX has 1.64 million shares outstanding. The number of shares has decreased by -6.36% in one year.

Current Share Class 1.64M
Shares Outstanding 1.64M
Shares Change (YoY) -6.36%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.30
PB Ratio 0.53
P/TBV Ratio 0.53
P/FCF Ratio 7.18
P/OCF Ratio 7.16
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 2.68
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -0.90

Financial Position

The company has a current ratio of 6.34

Current Ratio 6.34
Quick Ratio 4.93
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -2.48% and return on invested capital (ROIC) is -10.41%.

Return on Equity (ROE) -2.48%
Return on Assets (ROA) -2.42%
Return on Invested Capital (ROIC) -10.41%
Return on Capital Employed (ROCE) -4.66%
Weighted Average Cost of Capital (WACC) 9,099,911.33%
Revenue Per Employee 655,310
Profits Per Employee -9,197
Employee Count 28
Asset Turnover 1.49
Inventory Turnover 6.41

Taxes

Income Tax -21,217
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +33.20% in the last 52 weeks. The beta is 1,654,528.56, so PDRX's price volatility has been higher than the market average.

Beta (5Y) 1,654,528.56
52-Week Price Change +33.20%
50-Day Moving Average 3.52
200-Day Moving Average 4.22
Relative Strength Index (RSI) 58.29
Average Volume (20 Days) 1,453

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.11

Income Statement

In the last 12 months, PDRX had revenue of 18.35 million and -257,523 in losses. Loss per share was -0.16.

Revenue18.35M
Gross Profit 5.43M
Operating Income -477,417
Pretax Income -278,740
Net Income -257,523
EBITDA -327,971
EBIT -477,417
Loss Per Share -0.16
Full Income Statement

Balance Sheet

The company has 6.17 million in cash and n/a in debt, with a net cash position of 6.17 million or 3.75 per share.

Cash & Cash Equivalents 6.17M
Total Debt n/a
Net Cash 6.17M
Net Cash Per Share 3.75
Equity (Book Value) 10.24M
Book Value Per Share 6.23
Working Capital 8.94M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 765,032 and capital expenditures -2,439, giving a free cash flow of 762,593.

Operating Cash Flow 765,032
Capital Expenditures -2,439
Free Cash Flow 762,593
FCF Per Share 0.46
Full Cash Flow Statement

Margins

Gross margin is 29.61%, with operating and profit margins of -2.60% and -1.40%.

Gross Margin 29.61%
Operating Margin -2.60%
Pretax Margin -1.52%
Profit Margin -1.40%
EBITDA Margin -1.79%
EBIT Margin -2.60%
FCF Margin 4.16%

Dividends & Yields

PDRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 6.36%
Shareholder Yield 6.36%
Earnings Yield -4.70%
FCF Yield 13.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PDRX has an Altman Z-Score of 5.22 and a Piotroski F-Score of 3.

Altman Z-Score 5.22
Piotroski F-Score 3